NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

AEMD

Aethlon Medical Inc

Jul 11 • 04:00PM ET

1.18

Dollar change -0.05
Percentage change -3.67	%

Healthcare • Medical Devices • USA • NASD

Peers: VXRT ALT ADMA AVDL SNGX AXSM ANVS CVM MBRX INO

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-8.49	Insider Own	4.08%	Shs Outstand	2.59M	Perf Week	-4.84%
Market Cap	3.05M	Forward P/E	-	EPS next Y	-0.61	Insider Trans	0.00%	Shs Float	2.48M	Perf Month	-40.70%
Enterprise Value	-1.62M	PEG	-	EPS next Q	-0.86	Inst Own	16.30%	Short Float	6.26%	Perf Quarter	-58.22%
Income	-13.39M	P/S	-	EPS this Y	76.04%	Inst Trans	-11.96%	Short Ratio	0.72	Perf Half Y	-82.79%
Sales	0.00M	P/B	0.46	EPS next Y	70.08%	ROA	-171.58%	Short Interest	0.16M	Perf YTD	-82.85%
Book/sh	2.55	P/C	0.55	EPS next 5Y	60.97%	ROE	-245.88%	52W High	8.44 -86.02%	Perf Year	-64.42%
Cash/sh	2.13	P/FCF	-	EPS past 3/5Y	46.64% 43.53%	ROIC	-245.19%	52W Low	1.10 7.27%	Perf 3Y	-98.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	13.64% 12.92%	Perf 5Y	-99.22%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	78.21%	Oper. Margin	-	ATR (14)	0.23	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	3.13	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	34.63	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.13	EPS Q/Q	57.78%	SMA20	-19.93%	Beta	1.72	Target Price	3.02
Payout	-	Debt/Eq	0.16	Sales Q/Q	-	SMA50	-50.14%	Rel Volume	0.67	Prev Close	1.23
Employees	9	LT Debt/Eq	0.07	Earnings	Jun 26 AMC	SMA200	-65.99%	Avg Volume	214.45K	Price	1.18
IPO	May 11, 1994	Option/Short	No / Yes	EPS/Sales Surpr.	-200.01% -	Trades		Volume	144,929	Change	-3.67%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-07-25	Resumed	H.C. Wainwright	Neutral	$1.50

Jun-26-25 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update (PR Newswire) +23.57% -35.57%
Jun-20-25 08:01AM	Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025 (PR Newswire) -9.20%
Jun-18-25 08:01AM	Aethlon Medical Treats Second Patient in Australian Hemopurifier Cancer Trial (PR Newswire)
Jun-16-25 07:00AM	Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream (GlobeNewswire)
Jun-09-25 08:01AM	Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes (PR Newswire) -12.85%
08:01AM	Loading…
May-14-25 08:01AM	Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Platelet-Derived Extracellular Vesicles from Plasma (PR Newswire)
Mar-26-25 07:00AM	Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now (GlobeNewswire)
Mar-25-25 07:00AM	Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now (GlobeNewswire)
Mar-10-25 08:01AM	Aethlon Medical Publishes Preclinical Data on the Hemopurifier in Transplant Immunology Journal (PR Newswire) -5.54%
Feb-19-25 06:00AM	Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now (GlobeNewswire)
Feb-13-25 01:08PM	Q3 2025 Aethlon Medical Inc Earnings Call (Thomson Reuters StreetEvents) -5.51%
08:01AM	Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025 (PR Newswire)
Feb-12-25 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update (PR Newswire)
Feb-05-25 08:01AM	Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025 (PR Newswire) +8.57%
Jan-30-25 10:00AM	Aethlon Medical treats first subject with Hemopurifier device in Australia (Medical Device Network)
08:01AM	Loading…
Jan-29-25 08:01AM	Aethlon Medical Treats First Patient in Australian Hemopurifier Cancer Trial (PR Newswire) +18.96%
Dec-20-24 08:01AM	Aethlon Medical Provides Update on the Ability of Its Hemopurifier to Capture H5N1 Bird Flu (PR Newswire) +33.83%
Dec-04-24 07:00AM	Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now (GlobeNewswire)
Dec-03-24 07:00AM	Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now (GlobeNewswire)
Nov-14-24 08:00AM	Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally (Newsfile)
02:14AM	Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... (GuruFocus.com)
Nov-13-24 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update (PR Newswire)
Nov-12-24 08:00AM	Innovative Medical Technology Advances with First Patient Enrollments (Newsfile) -7.84%
Nov-11-24 11:18AM	Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer (Medical Device Network) +5.98%
08:01AM	Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in Australia (PR Newswire)
Nov-06-24 08:01AM	Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024 (PR Newswire)
Oct-30-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now (GlobeNewswire)
Oct-29-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now (GlobeNewswire)
Oct-09-24 06:26PM	Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ... (GuruFocus.com)
Oct-08-24 08:01AM	Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit (PR Newswire) -7.03%
07:00AM	Loading…
Sep-25-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 2 on September 26 (GlobeNewswire)
Sep-24-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now (GlobeNewswire)
Sep-20-24 08:35AM	Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing (GlobeNewswire) -8.21%
Sep-19-24 10:00AM	Immunotherapy Clinical Trials - A New Approach to Treating Cancer (Newsfile) +8.82%
08:01AM	Aethlon Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India (PR Newswire)
Sep-17-24 08:01AM	Aethlon Medical to Present at Virtual Investor Conferences in September (PR Newswire)
03:30AM	Innovation Driving Cancer's Solid Tumors Market (Newsfile)
Sep-16-24 12:07PM	Life Sciences Virtual Investor Forum Agenda Announced for September 19th (GlobeNewswire)
08:01AM	Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial (PR Newswire)
Sep-13-24 08:35AM	Aethlon Medical to Present at the Life Sciences Investor Forum September 19th (GlobeNewswire)
Aug-27-24 08:01AM	Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys (PR Newswire) -7.36%
Aug-14-24 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update (PR Newswire) +15.93% -16.86%
Aug-13-24 06:53AM	Aethlon Medical receives ethics committee approval for trial of cancer treatment (Clinical Trials Arena) +6.22%
Aug-12-24 09:01AM	The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors (Newsfile)
08:01AM	Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial (PR Newswire)
Aug-06-24 09:12AM	Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024 (PR Newswire) +11.54%
Jun-28-24 08:03AM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript (Insider Monkey) -13.81%
Jun-27-24 08:52PM	AEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024 (InvestorPlace)
04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update (PR Newswire)
Jun-21-24 08:01AM	Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 (PR Newswire)
Jun-20-24 07:00AM	What's Next in Treatments for Cancer Patients with Solid Tumors? (Newsfile) -12.59%
Jun-18-24 08:01AM	Aethlon Medical Receives Ethics Committee Approval for Hemopurifier Cancer Trial (PR Newswire) +5.37%
Jun-07-24 08:00AM	The Hunt for Virus Treatments Continues Post Covid-19 (Newsfile) +6.51%
Jun-06-24 08:12AM	Why Is Aethlon Medical (AEMD) Stock Up 82% Today? (InvestorPlace) +25.42%
07:38AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jun-03-24 09:05AM	Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID (Newsfile) +5.26%
08:01AM	Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies (PR Newswire)
May-15-24 01:34PM	Top Midday Decliners (MT Newswires) -52.95%
09:15AM	Aethlon Medical Announces Pricing of $4.7 Million Public Offering (PR Newswire)
07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-10-24 08:01AM	Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles From Cancer Patient Plasma (PR Newswire)
Feb-21-24 08:01AM	Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices (PR Newswire)
Feb-15-24 10:03AM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript (Insider Monkey) -5.20%
Feb-14-24 04:15PM	Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
Feb-07-24 08:00AM	Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 (PR Newswire)
Nov-16-23 09:35AM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:15PM	Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update (PR Newswire) +7.55%
Nov-13-23 08:01AM	Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (PR Newswire)
Nov-06-23 08:01AM	Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 (PR Newswire)
Oct-12-23 10:19AM	AEMD: Authorization to Conduct Study in India Moves Oncology Initiatives Ahead (Zacks)
Oct-10-23 08:01AM	Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier in Oncology (PR Newswire)
Oct-04-23 08:01AM	Aethlon Announces Reverse Stock Split (PR Newswire) -10.86%
Aug-30-23 08:01AM	Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire)
Aug-14-23 08:03AM	AEMD: Focusing on Oncology, Infectious Disease & Organ Transplants Initially (Zacks)
Aug-10-23 04:15PM	Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update (PR Newswire)
Aug-03-23 08:01AM	Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023 (PR Newswire)
Jul-24-23 08:01AM	Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant (PR Newswire)
Jul-06-23 02:17PM	Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors (PR Newswire) +25.00%
12:10PM	AEMD: Expanding Research Efforts & Strengthening Team, While Minimizing R&D Spending (Zacks)
Jun-30-23 12:42PM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.82%
Jun-28-23 04:15PM	Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update (PR Newswire) +7.85% -5.07%
Jun-22-23 08:01AM	Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023 (PR Newswire)
Jun-21-23 08:01AM	Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation (PR Newswire)
Jun-14-23 08:01AM	Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest (PR Newswire)
Jun-08-23 09:13AM	AEMD: Maximizing R&D Spending to Facilitate Clinical Efforts, Advance Hemopurifier (Zacks Small Cap Research)
Jun-01-23 03:51PM	Aethlon Medical to Present at the 13th Annual LD Micro Invitational (PR Newswire)
May-22-23 08:01AM	Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India (PR Newswire)
Feb-17-23 06:53AM	Aethlon Medical Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.16 loss in 3Q 2022) (Simply Wall St.)
Feb-16-23 06:52AM	Analysts Expect Aethlon Medical, Inc. (NASDAQ:AEMD) To Breakeven Soon (Simply Wall St.)
Feb-15-23 08:41AM	AEMD: New CRO to Help Advance Studies; Expanded Team to Facilitate Efforts (Zacks Small Cap Research)
Feb-14-23 04:42PM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2023 Earnings Call Transcript (Insider Monkey)
Feb-13-23 04:15PM	Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
Jan-31-23 08:01AM	Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023 (PR Newswire) -7.55%
Jan-30-23 08:01AM	Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer (PR Newswire) +33.49%
Nov-16-22 11:10AM	AEMD: Hemopurifier Hemopurifier To Be Studied in a Variety of Solid Tumors (Zacks Small Cap Research)
Nov-14-22 04:15PM	Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update (PR Newswire) -8.34%
Nov-02-22 02:43PM	Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022 (PR Newswire) -5.61%
Sep-12-22 08:35AM	Life Sciences Virtual Investor Conference Agenda Announced for September 15th (GlobeNewswire) +9.74%
Sep-06-22 08:01AM	Aethlon Medical to Present at Two Investor Conferences in September (PR Newswire)
Aug-17-22 11:42AM	AEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkey Pox (Zacks Small Cap Research) +7.09%

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AEMD

Aethlon Medical Inc

Upgrade your FINVIZ experience